The MSCI World Index of developed market (DM) equities has risen by ~6% since COVID-19 vaccination programmes started in early December and hit another record high yesterday. While the magnitude of these gains may not seem remarkable in comparison to the November rally, three features stand out.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services